FDA-Inspected Site

Intra-Cellular Therapies Inc

2 FDA inspections are on record for Intra-Cellular Therapies Inc in New York, United States.

Clean· No action indicated

New York, United States · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2024-07-31.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
29 Jul 2024 – 31 Jul 2024Human DrugsClean
11 Mar 2019 – 22 Mar 2019Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

22 Mar 2019
21 CFR 312.50

General responsibilities of sponsors

Cited by Iram R Hassan, Diane C Van Leeuwen, Bei Yu, Ni A Khin

22 Mar 2019
21 CFR 312.50

Ensuring compliance with plan and protocol

Cited by Iram R Hassan, Diane C Van Leeuwen, Bei Yu, Ni A Khin

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations2x

Full site report

Get the verbatim findings behind Intra-Cellular Therapies Inc's 1 Form 483

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat